相似文献
1
Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.
Immunology. 1987 Feb;60(2):181-6.
2
Characterization of syngeneic rat monoclonal antibodies to the HSN tumor using syngeneic monoclonal anti-idiotopic antibodies.
J Immunol. 1991 Apr 15;146(8):2879-86.
3
Anti-idiotypic antibodies: powerful tools in diagnosis and therapy.
Behring Inst Mitt. 1988 Apr(82):182-92.
4
Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
Immunology. 1982 Nov;47(3):397-405.
5
Humoral immunity to rat sarcomata induced by syngeneic monoclonal anti-idiotype antibody.
Monogr Allergy. 1987;22:222-4.
6
Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.
Immunology. 1983 Aug;49(4):667-71.
7
[Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Zentralbl Gynakol. 1999;121(4):190-5.
8
9
10
Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.
Cancer Res. 1995 Apr 1;55(7):1525-30.
引用本文的文献
1
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
J Immunother Cancer. 2022 May;10(5). doi: 10.1136/jitc-2021-004007.
2
Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma.
Cancer Immunol Immunother. 2009 Jul;58(7):1117-28. doi: 10.1007/s00262-008-0634-y. Epub 2008 Dec 10.
3
Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21.
Immunology. 1989 Jan;66(1):26-31.
4
Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice.
Br J Cancer. 2004 May 17;90(10):2032-41. doi: 10.1038/sj.bjc.6601825.
5
Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
Cancer Immunol Immunother. 1993 May;36(5):281-92. doi: 10.1007/BF01741166.
6
Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.
J Clin Invest. 1995 Jul;96(1):334-42. doi: 10.1172/JCI118039.
7
Possible role of anti-idiotypic antibodies in the induction of tumor immunity.
J Clin Invest. 1987 Nov;80(5):1217-24. doi: 10.1172/JCI113195.
8
Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.
Immunology. 1989 Aug;67(4):525-30.
9
Effects of anti-idiotype vaccine on tumour growth and on production of soluble factors modulating cell-mediated immunity in vitro.
Cancer Immunol Immunother. 1991;33(3):171-6. doi: 10.1007/BF01756138.
10
Human response against NP-4, a mouse antibody to carcinoembryonic antigen: human anti-idiotype antibodies mimic an epitope on the tumor antigen.
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3421-5. doi: 10.1073/pnas.88.8.3421.
本文引用的文献
1
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
2
Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
Cancer Res. 1960 Dec;20:1561-72.
3
The biological half-lives of four rat immunoglobulin isotypes.
Immunology. 1980 Aug;40(4):683-6.
4
Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
Immunology. 1982 Nov;47(3):397-405.
5
Suppression of tumor rejection by autologous anti-idiotypic immunity.
Proc Natl Acad Sci U S A. 1980 Apr;77(4):2209-13. doi: 10.1073/pnas.77.4.2209.
6
Altered tumor growth in vivo after immunization of mice with antitumor antibodies.
Cancer Res. 1984 Aug;44(8):3291-8.
7
Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.
Proc Natl Acad Sci U S A. 1984 May;81(9):2864-7. doi: 10.1073/pnas.81.9.2864.
8
Subclass restriction of the antiidiotypic antibody response in the rat.
Ann Immunol (Paris). 1983 Sep-Oct;134D(2):167-79. doi: 10.1016/s0771-050x(83)80084-9.
9
Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
Proc Natl Acad Sci U S A. 1984 Jan;81(1):216-9. doi: 10.1073/pnas.81.1.216.
10
Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.
J Exp Med. 1984 Oct 1;160(4):1001-11. doi: 10.1084/jem.160.4.1001.
Zotero 插件